{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:10:44Z","timestamp":1790482244861,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.trre.2021.100610","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T11:19:41Z","timestamp":1614424781000},"page":"100610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review"],"prefix":"10.1016","volume":"35","author":[{"given":"H.E.","family":"Braithwaite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Darley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.O.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.E.","family":"Carland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2021.100610_bb0005","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2165\/00003495-200363120-00006","article-title":"Tacrolimus: a further update of its use in the management of organ transplantation","volume":"63","author":"Scott","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2021.100610_bb0010","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/ajt.13309","article-title":"Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation","volume":"15","author":"Sikma","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0015","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2215\/CJN.04800512","article-title":"Recovery from AKI and short- and long-term outcomes after lung transplantation","volume":"8","author":"Wehbe","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2021.100610_bb0020","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00228-017-2204-8","article-title":"High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury","volume":"73","author":"Sikma","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.trre.2021.100610_bb0025","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1600-6143.2006.01248.x","article-title":"Kidney disease after heart and lung transplantation","volume":"6","author":"Bloom","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0030","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2337\/dc14-0663","article-title":"Prevalence and predictors of diabetes after lung transplantation: a prospective, longitudinal study","volume":"37","author":"Hackman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trre.2021.100610_bb0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ejcts.2008.01.050","article-title":"Post-transplant diabetes mellitus in lung transplant recipients: incidence and risk factors","volume":"33","author":"Ollech","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.trre.2021.100610_bb0040","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.healun.2014.08.003","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first official adult heart transplant report--2014; focus theme: retransplantation","volume":"33","author":"Lund","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0045","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00003495-200059020-00021","article-title":"Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation","volume":"59","author":"Plosker","year":"2000","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2021.100610_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","article-title":"Therapeutic drug monitoring of tacrolimus-personalized therapy: Second consensus Report","volume":"41","author":"Brunet","year":"2019","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.trre.2021.100610_bb0055","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s40262-016-0396-1","article-title":"Population pharmacokinetic modelling and Bayesian estimation of tacrolimus exposure: is this clinically useful for dosage prediction yet?","volume":"55","author":"Brooks","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2021.100610_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0004-9514(09)70043-1","article-title":"The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study","volume":"55","author":"de Morton","year":"2009","journal-title":"Aust J Physiother"},{"key":"10.1016\/j.trre.2021.100610_bb0065","series-title":"The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses","author":"Wells","year":"2011"},{"key":"10.1016\/j.trre.2021.100610_bb0070","doi-asserted-by":"crossref","first-page":"295","DOI":"10.12659\/AOT.890268","article-title":"Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation","volume":"19","author":"Urbanowicz","year":"2014","journal-title":"Ann Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0075","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1097\/00007890-200210270-00014","article-title":"Tacrolimus in cardiac transplantation: efficacy and safety of a novel dosing protocol","volume":"74","author":"Baran","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100610_bb0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13318-019-00591-7","article-title":"High variability of whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation","volume":"45","author":"Sikma","year":"2020","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.trre.2021.100610_bb0085","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.transproceed.2012.09.062","article-title":"Effect of CYP3A5, CYP3A4, and ABCB1 genotypes as determinants of tacrolimus dose and clinical outcomes after heart transplantation","volume":"44","author":"Diaz-Molina","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100610_bb0090","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S1053-2498(99)00036-4","article-title":"Optimal dosing of intravenous tacrolimus following pediatric heart transplantation","volume":"18","author":"Robinson","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0095","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/j.transproceed.2015.10.052","article-title":"Race, calcineurin inhibitor exposure, and renal function after solid organ transplantation","volume":"47","author":"Yessayan","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100610_bb0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.healun.2006.11.008","article-title":"Determinants of renal function in pediatric heart transplant recipients: long-term follow-up study","volume":"26","author":"Sachdeva","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00007890-199107000-00015","article-title":"The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver","volume":"52","author":"Abu-Elmagd","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100610_bb0110","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1097\/00007890-200112150-00026","article-title":"Severe axonal polyneuropathy after a FK506 overdosage in a lung transplant recipient","volume":"72","author":"Boukriche","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100610_bb0115","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.pediatrneurol.2013.11.006","article-title":"Alternative tacrolimus and sirolimus regimen associated with rapid resolution of posterior reversible encephalopathy syndrome after lung transplantation","volume":"50","author":"Hayes","year":"2014","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.trre.2021.100610_bb0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1034\/j.1399-0012.2003.00071.x","article-title":"Impairment of the blood-brain barrier can result in tacrolimus-induced reversible leucoencephalopathy following heart transplantation","volume":"17","author":"Kaczmarek","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0125","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3821\/1913-701X-142.2.68","article-title":"Macrolide antibiotics and calcineurin inhibitors: Avoiding a far too common drug interaction in transplant patients","volume":"142","author":"Mansell","year":"2009","journal-title":"Can Pharm J"},{"key":"10.1016\/j.trre.2021.100610_bb0130","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/cpt.1629","article-title":"Early tacrolimus concentrations after lung transplant are predicted by combined clinical and genetic factors and associated with acute kidney injury","volume":"107","author":"Miano","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trre.2021.100610_bb0135","doi-asserted-by":"crossref","first-page":"487","DOI":"10.12659\/AJCR.903403","article-title":"Posterior reversible encephalopathy syndrome after orthotopic heart transplantation: a case report","volume":"18","author":"Ramirez","year":"2017","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.trre.2021.100610_bb0140","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s13318-017-0453-7","article-title":"Association of whole blood tacrolimus concentrations with kidney injury in heart transplantation patients","volume":"43","author":"Sikma","year":"2018","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.trre.2021.100610_bb0145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1445-5994.2010.02314.x","article-title":"Reversible posterior leukoencephalopathy syndrome: diagnosis and management in the setting of lung transplantation","volume":"40","author":"Tsang","year":"2010","journal-title":"Intern Med J"},{"key":"10.1016\/j.trre.2021.100610_bb0150","first-page":"275","article-title":"New-onset diabetes mellitus in pediatric thoracic organ recipients receiving tacrolimus-based immunosuppression","volume":"16","author":"Wagner","year":"1997","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0155","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2710.2006.00697.x","article-title":"Relationships of tacrolimus pharmacokinetic measures and adverse outcomes in stable adult liver transplant recipients","volume":"31","author":"Dansirikul","year":"2006","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.trre.2021.100610_bb0160","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2021.100610_bb0165","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/ctr.12581","article-title":"Switching STudy of kidney TRansplant PAtients with tremor to LCP-TacrO (STRATO): an open-label, multicenter, prospective phase 3b study","volume":"29","author":"Langone","year":"2015","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0170","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1097\/TP.0000000000001797","article-title":"Targeting high Calcineurin inhibitor levels after acute rejection with less tremor: a new strategy","volume":"101","author":"Alhamad","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100610_bb0175","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/00007890-200111270-00014","article-title":"Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors","volume":"72","author":"Maes","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100610_bb0180","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ijsu.2017.12.037","article-title":"Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation","volume":"51","author":"Song","year":"2018","journal-title":"Int J Surg"},{"key":"10.1016\/j.trre.2021.100610_bb0185","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12882-017-0553-2","article-title":"Renal association clinical practice guideline in post-operative care in the kidney transplant recipient","volume":"18","author":"Baker","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.trre.2021.100610_bb0190","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s12072-020-10091-5","article-title":"Immunosuppressive regimens for adult liver transplant recipients in real-life practice: Consensus recommendations from an Italian working group","volume":"14","author":"Cillo","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.trre.2021.100610_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1681\/ASN.V131277","article-title":"Gastrointestinal complications of transplant immunosuppression","volume":"13","author":"Helderman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2021.100610_bb0200","first-page":"3106","article-title":"Gastrointestinal toxicity associated with FK 506 in liver transplant recipients","volume":"26","author":"Fisher","year":"1994","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2021.100610_bb0205","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 kidney transplant study group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2021.100610_bb0210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.21037\/atm.2019.12.117","article-title":"Immunosuppressive strategies in lung transplantation","volume":"8","author":"Chung","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.trre.2021.100610_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111128","article-title":"The tacrolimus metabolism rate influences renal function after kidney transplantation","volume":"9","author":"Tholking","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trre.2021.100610_bb0220","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/14740338.2019.1599858","article-title":"An update on the safety of tacrolimus in kidney transplant recipients, with a focus on tacrolimus minimization","volume":"18","author":"Jouve","year":"2019","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.trre.2021.100610_bb0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12659\/AOT.895898","article-title":"Tacrolimus concentration\/dose ratio is associated with renal function after liver transplantation","volume":"21","author":"Tholking","year":"2016","journal-title":"Ann Transplant"},{"key":"10.1016\/j.trre.2021.100610_bb0230","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s40262-019-00854-1","article-title":"Unbound plasma, Total plasma, and whole-blood tacrolimus pharmacokinetics early after thoracic organ transplantation","volume":"59","author":"Sikma","year":"2020","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.trre.2021.100610_bb0235","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s40262-020-00922-x","article-title":"Population pharmacokinetic models of tacrolimus in adult transplant recipients: a systematic review","volume":"59","author":"Kirubakaran","year":"2020","journal-title":"Clin Pharmacokinet"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X21000161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T16:07:17Z","timestamp":1760630837000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X21000161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0955470X21000161"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2021.100610","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identifying the association between tacrolimus exposure and toxicity in heart and lung transplant recipients: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Transplantation Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trre.2021.100610","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100610"}}